Cargando…
Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial
Introduction: Oncologists have traditionally administered the maximum tolerated doses of drugs in chemotherapy. However, these toxicity-guided doses may lead to suboptimal efficacy. CURATE.AI is an indication-agnostic, mechanism-independent and efficacy-driven personalised dosing platform that may o...
Autores principales: | Tan, Benjamin Kye Jyn, Teo, Chong Boon, Tadeo, Xavier, Peng, Siyu, Soh, Hazel Pei Lin, Du, Sherry De Xuan, Luo, Vilianty Wen Ya, Bandla, Aishwarya, Sundar, Raghav, Ho, Dean, Kee, Theodore Wonpeum, Blasiak, Agata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521832/ https://www.ncbi.nlm.nih.gov/pubmed/34713106 http://dx.doi.org/10.3389/fdgth.2021.635524 |
Ejemplares similares
-
A Limb Hypothermia Wearable for Chemotherapy-Induced Peripheral Neuropathy: A Mixed-Methods Approach in Medical Product Development
por: Binder, Jonathan, et al.
Publicado: (2020) -
Personalised Dosing Using the CURATE.AI Algorithm: Protocol for a Feasibility Study in Patients with Hypertension and Type II Diabetes Mellitus
por: Mukhopadhyay, Amartya, et al.
Publicado: (2022) -
Physicians’ Perspectives on AI in Clinical Decision Support Systems: Interview Study of the CURATE.AI Personalized Dose Optimization Platform
por: Vijayakumar, Smrithi, et al.
Publicado: (2023) -
Editorial: Non-invasive Technology Advances in Oncology
por: Teo, Chong Boon, et al.
Publicado: (2021) -
CURATE.AI COR-Tx platform as a digital therapy and digital diagnostic for cognitive function in patients with brain tumour postradiotherapy treatment: protocol for a prospective mixed-methods feasibility clinical trial
por: Remus, Alexandria, et al.
Publicado: (2023)